Scott Andrew Smith is of BioAtla, Inc.. Currently has a direct ownership of 298,050 shares of BCAB, which is worth approximately $485,821. The most recent transaction as insider was on Aug 31, 2022, when has been sold 1,791 shares (Common Stock) at a price of $8.71 per share, resulting in proceeds of $15,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 298K
1.44% 3M change
2.08% 12M change
Total Value Held $485,821

Scott Andrew Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2022
SELL
Payment of exercise price or tax liability
$15,600 $8.71 p/Share
1,791 Reduced 0.54%
328,044 Common Stock
Jul 31 2022
SELL
Payment of exercise price or tax liability
$6,089 $3.4 p/Share
1,791 Reduced 0.54%
329,835 Common Stock
Jun 30 2022
SELL
Payment of exercise price or tax liability
$5,104 $2.85 p/Share
1,791 Reduced 0.54%
331,626 Common Stock
May 31 2022
SELL
Payment of exercise price or tax liability
$4,316 $2.41 p/Share
1,791 Reduced 0.53%
333,417 Common Stock
Apr 30 2022
SELL
Payment of exercise price or tax liability
$6,233 $3.48 p/Share
1,791 Reduced 0.53%
335,208 Common Stock
Mar 31 2022
SELL
Payment of exercise price or tax liability
$8,955 $5.0 p/Share
1,791 Reduced 0.53%
336,999 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$11,606 $6.48 p/Share
1,791 Reduced 0.53%
338,790 Common Stock
Jan 31 2022
SELL
Payment of exercise price or tax liability
$20,850 $9.56 p/Share
2,181 Reduced 0.64%
340,581 Common Stock
Dec 31 2021
SELL
Payment of exercise price or tax liability
$56,809 $19.63 p/Share
2,894 Reduced 0.84%
342,762 Common Stock
Dec 02 2021
SELL
Open market or private sale
$65,976 $22.11 p/Share
2,984 Reduced 0.86%
345,656 Common Stock
Dec 01 2021
SELL
Open market or private sale
$14,588 $23.23 p/Share
628 Reduced 0.18%
348,640 Common Stock
Nov 30 2021
SELL
Open market or private sale
$11,802 $24.69 p/Share
478 Reduced 0.14%
349,268 Common Stock
Nov 29 2021
SELL
Open market or private sale
$9,532 $23.89 p/Share
399 Reduced 0.11%
349,746 Common Stock
Nov 24 2021
SELL
Open market or private sale
$11,622 $24.94 p/Share
466 Reduced 0.13%
350,145 Common Stock
Nov 23 2021
SELL
Open market or private sale
$17,216 $25.17 p/Share
684 Reduced 0.19%
350,611 Common Stock
Nov 22 2021
SELL
Open market or private sale
$11,279 $26.23 p/Share
430 Reduced 0.12%
351,295 Common Stock
Oct 01 2021
SELL
Open market or private sale
$90,359 $30.18 p/Share
2,994 Reduced 0.84%
351,725 Common Stock
Aug 26 2021
SELL
Open market or private sale
$1,338,403 $40.26 p/Share
33,244 Reduced 8.57%
354,719 Common Stock
Jun 14 2021
BUY
Other acquisition or disposition
-
34,963 Added 8.27%
387,963 Common Stock

Also insider at

VTRS
Viatris Inc Healthcare
BCAC
Brookline Capital Acquisition Corp. Financial Services
SAS

Scott Andrew Smith

San Diego, CA

Track Institutional and Insider Activities on BCAB

Follow BioAtla, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCAB shares.

Notify only if

Insider Trading

Get notified when an Bio Atla, Inc. insider buys or sells BCAB shares.

Notify only if

News

Receive news related to BioAtla, Inc.

Track Activities on BCAB